Monocytosis Diagnosis and Management

Introduction to Monocytosis

Monocytosis has two major categories: reactive (benign) conditions from chronic infections and inflammation, and clonal hematologic malignancies, particularly chronic myelomonocytic leukemia (CMML) 1

Chronic infections, specifically tuberculosis and bacterial endocarditis, are common infectious triggers for monocytosis 1
Viral infections, including HIV and hepatitis C, can produce monocytosis clinically indistinguishable from primary hematologic disorders 2
Ehrlichiosis presents with monocytosis alongside leukopenia, thrombocytopenia, and elevated hepatic transaminases; look for morulae within monocytes on peripheral smear 2
Parasitic infections, particularly Strongyloides in patients with travel history, can cause monocytosis 2
Adult-onset Still's disease produces marked leukocytosis with monocytosis, typically with white blood cell counts >15×10⁹ cells/L 1
Inflammatory bowel disease causes chronic monocyte elevation 1, 2
Systemic lupus erythematosus and other autoimmune disorders frequently elevate monocyte counts 2
Rheumatoid arthritis is associated with elevated monocyte percentages 2
Chronic inflammatory conditions trigger monocyte expansion through persistent cytokine stimulation 1
Atherosclerosis and coronary artery disease correlate with elevated monocyte counts, as monocytes play a pathogenic role in plaque formation 1
Hypertension is associated with increased CD14++CD16+ monocyte populations that independently predict cardiovascular events 3

CMML is the primary hematologic malignancy causing persistent monocytosis and carries the highest relative risk (OR 105.22, 95% CI: 38.27-289.30) 1
WHO 2008 criteria for CMML require: persistent peripheral blood monocytosis (>1×10⁹/L), absence of Philadelphia chromosome or BCR-ABL1 fusion gene, and <20% blasts in blood and bone marrow 1
Molecular mutations commonly found in CMML include TET2, SRSF2, ASXL1, and RAS 1
Chronic lymphocytic leukemia: elevated absolute monocyte count correlates with inferior outcomes and accelerated disease progression 2
Myelodysplastic syndromes can present with monocytosis, though absolute monocyte count typically remains <1×10⁹/L 2

Obtain absolute monocyte count, not just percentage; monocytosis is defined as ≥1×10⁹/L 1, 2
Detailed history focusing on: travel exposure, new medications, recurrent infections, family history of hematologic malignancies, constitutional symptoms, and chronic inflammatory conditions 2
Physical examination must assess spleen size, cutaneous lesions, lymphadenopathy, and signs of organ damage 2
Complete blood count with differential to determine absolute monocyte count and assess for concurrent cytopenias 2
Peripheral blood smear examination to evaluate monocyte morphology, dysgranulopoiesis, promonocytes, blasts, neutrophil precursors, rouleaux formation, and morulae in monocytes 2
Bone marrow evaluation is mandated for: persistent unexplained monocytosis without clear reactive cause, absolute monocyte count ≥1×10⁹/L sustained over time, concurrent cytopenias or other blood count abnormalities, constitutional symptoms or organomegaly, and dysplastic features on peripheral smear 1, 2
Bone marrow aspiration and biopsy with Gomori's silver impregnation for fibrosis to assess marrow cellularity, dysplasia, and blast percentage 2
Conventional cytogenetic analysis to exclude t(9;22) and t(5;12) translocations and identify clonal abnormalities 2
Molecular testing for BCR-ABL1 fusion gene and mutations in TET2, SRSF2, ASXL1, and RAS genes 1, 2